PHILADELPHIA, April 16, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced that Recursion (NASDAQ: RXRX), a ...

Andrew Kress, CEO of HealthVerity, emphasized the transformative impact of RWD on clinical trials, stating that access to extensive real-world data allows companies like Recursion to make informed ...

Ph.D., former CSO and Interim CEO of Exscientia and newly appointed Chief Scientific Officer at Recursion. “With our combined strength of real-world proprietary data and the models we’ve ...